CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIU) — FDA Approval ANDA213530 (CHARTWE
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIU) — FDA Approval ANDA213530 (CHARTWE is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE; Active ingredients: CHLORDIAZEPOXIDE HYDROCHLORI
| Brand name | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE |
|---|---|
| Active ingredients | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
| Application number | ANDA213530 |
| Sponsor | CHARTWELL RX |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20201020 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →